ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 183 filers reported holding ARCUS BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $270 | -42.8% | 17,722 | -22.4% | 0.03% | -36.2% |
Q4 2022 | $472 | -99.8% | 22,830 | +218.8% | 0.05% | +104.3% |
Q1 2021 | $201,000 | -7.4% | 7,161 | -14.2% | 0.02% | -34.3% |
Q4 2020 | $217,000 | -23.9% | 8,343 | -49.9% | 0.04% | -23.9% |
Q3 2020 | $285,000 | -29.5% | 16,639 | +1.8% | 0.05% | -24.6% |
Q2 2020 | $404,000 | – | 16,340 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 1,612,077 | $29,404,284 | 19.15% |
Decheng Capital Management III (Cayman), LLC | 869,790 | $15,864,970 | 6.40% |
Octagon Capital Advisors LP | 2,172,000 | $39,617,280 | 5.70% |
Boxer Capital, LLC | 1,432,200 | $26,123 | 1.28% |
PFM Health Sciences, LP | 1,559,947 | $28,453,433 | 1.26% |
SECTORAL ASSET MANAGEMENT INC | 293,646 | $5,356,103 | 1.03% |
DAFNA Capital Management LLC | 175,217 | $3,195,958 | 0.96% |
Ikarian Capital, LLC | 230,000 | $4,195,200 | 0.95% |
Tejara Capital Ltd | 50,000 | $912,000 | 0.47% |
Capital Impact Advisors, LLC | 20,501 | $373,938 | 0.46% |